J. P. Life Science Private Limited
Produces and supplies pharmaceuticals, medicinal chemicals, and botanical products globally.
2008 | Ahmedabad, Gujarat (India) | Active
J. P. Life Science Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 17 Year, 23 Days
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.76 M
- Revenue Growth 48.31%
- Profit Growth 77.85%
- Ebitda 247.59%
- Net Worth 38.51%
- Total Assets 60.98%
About J. P. Life Science
J. P. Life Science Private Limited (JPLSPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 February 2008 and has a history of 17 years. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹4.76 M.
Jayesh Pandya, Altafhusain Agwan, and Ritul Panchal serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24232GJ2008PTC052822
- Company No.
052822
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Feb 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Pharma
Who are the key members and board of directors at J. P. Life Science?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayesh Pandya  | Director | 05-Feb-2008 | Current |
| Altafhusain Agwan | Director | 15-Feb-2008 | Current |
| Ritul Panchal | Director | 08-Sep-2010 | Current |
Financial Performance of J. P. Life Science.
J. P. Life Science Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 48.31% increase. The company also saw a substantial improvement in profitability, with a 77.85% increase in profit. The company's net worth Soared by an impressive increase of 38.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of J. P. Life Science?
In 2019, J. P. Life Science had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Nikol Health Care Private Limited
Jayesh Pandya is a mutual person
Charges (Loans)
Open Charges
₹4.76 M
Satisfied Charges
₹0
Charges Breakdown by Lending Institutions
- Others : 0.48 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Sep 2020 | Others | ₹4.76 M | Open |
How Many Employees Work at J. P. Life Science?
Unlock and access historical data on people associated with J. P. Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of J. P. Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped J. P. Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
